Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 8—August 2002
Research

Outbreak of Serogroup W135 Meningococcal Disease after the Hajj Pilgrimage, Europe, 2000

Jean-François Aguilera*Comments to Author , Anne Perrocheau†, Christine Meffre‡, Susan Hahné§, and the W135 Working Group1
Author affiliations: *Communicable Disease Surveillance Centre, London, United Kingdom; †Institut de Veille Sanitaire, St. Maurice, France; ‡Rijksinstituut voor Volksgezondheid en Milieu (RIVM), European Programme for Intervention Epidemiology Training, Bilthoven, the Netherlands; §Communicable Disease Surveillance Centre, Cardiff, Wales, United Kingdom

Main Article

Table 2

Characteristics of pilgrim and contact cases in Europe following the Hajj, 2000

Pilgrims Household contacts Outside-of- household contacts No identified contact
No. of cases 12 31 21 26
Mean age (yrs) 50.0 16.0 6.9 25.8
Sex ratio (M/F) 4/8 13/18 13/8 10/13a
Median no. of bedrooms in household 3.0 2.5 2.5 2.0
Median no. of rooms in household 6.0 5.0 5.5 4.0
CFR 5/12 (41.7%) 3/31 (9.7%) 1/18 (5.6%) 5/21 (23.8%)

a Sex not known for three cases.
CFR, case-fatality rate.

Main Article

1F. Carion and O. Ronveaux, Institut de Santé Publique, Brussels, Belgium; P. Nuorti, H. Kayhty, and N. Nguyen Tran Minh, Kansanterveyslaitos Folkhälsoinstitutet, National Public Health Institute, Helsinki, Finland; T. Breuer, U. Menzel, and V. Bremer, Robert Koch Institute, Berlin, Germany; J. Kool, Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven, the Netherlands; L. Spanjaard, Netherlands Reference Laboratory for Bacterial Meningitis, Amsterdam, the Netherlands; M. Arneborn and H. Götz, Smittskyddinstitutet, Stockholm, Sweden; P.Olcen, National Meningitidis Reference Laboratory, Örebro, Sweden; M. Ramsay, N. Noah, and E. Kaczmarski, Public Health Laboratory Service (PHLS), London, United Kingdom; J. Stuart, PHLS, Gloucester, United Kingdom; D. Levy-Bruhl, M.D. Matsika-Claquin, and J.C. Desenclos, Institut National de Veille Sanitaire, St-Maurice, France; M.K. Taha, Institut Pasteur, Paris, France; B. Iversen and D. Caugant, Folkehelsa, Oslo, Norway.

Page created: July 16, 2010
Page updated: July 16, 2010
Page reviewed: July 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external